- Home
- RPRX vs APG Comparison
RPRX vs APG Comparison
Compare RPRX & APG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- APG
- Stock Information
- Founded
- RPRX 1996
- APG 1926
- Country
- RPRX United States
- APG United States
- Employees
- RPRX N/A
- APG N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- APG Engineering & Construction
- Sector
- RPRX Health Care
- APG Consumer Discretionary
- Exchange
- RPRX Nasdaq
- APG Nasdaq
- Market Cap
- RPRX 15.6B
- APG 14.6B
- IPO Year
- RPRX 2020
- APG N/A
- Fundamental
- Price
- RPRX $36.03
- APG $34.38
- Analyst Decision
- RPRX Strong Buy
- APG Strong Buy
- Analyst Count
- RPRX 4
- APG 10
- Target Price
- RPRX $44.50
- APG $36.70
- AVG Volume (30 Days)
- RPRX 5.2M
- APG 2.2M
- Earning Date
- RPRX 11-05-2025
- APG 10-30-2025
- Dividend Yield
- RPRX 2.44%
- APG N/A
- EPS Growth
- RPRX 54.86
- APG N/A
- EPS
- RPRX 2.32
- APG 0.34
- Revenue
- RPRX $2,305,243,000.00
- APG $7,396,000,000.00
- Revenue This Year
- RPRX $35.14
- APG $11.51
- Revenue Next Year
- RPRX $1.24
- APG $5.78
- P/E Ratio
- RPRX $15.51
- APG $101.56
- Revenue Growth
- RPRX 3.02
- APG 7.59
- 52 Week Low
- RPRX $24.05
- APG $20.50
- 52 Week High
- RPRX $38.00
- APG $36.55
- Technical
- Relative Strength Index (RSI)
- RPRX 51.05
- APG 45.43
- Support Level
- RPRX $35.36
- APG $34.06
- Resistance Level
- RPRX $36.67
- APG $34.58
- Average True Range (ATR)
- RPRX 0.74
- APG 0.65
- MACD
- RPRX 0.08
- APG 0.02
- Stochastic Oscillator
- RPRX 68.36
- APG 40.65
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About APG APi Group Corporation
APi Group Corp operates in two segments: Safety Services segment includes providing safety services in North America, Asia Pacific, and Europe, focusing on end-to-end integrated occupancy systems (fire protection solutions, Heating, Ventilation, and Air Conditioning and entry systems), including design, installation, inspection, and service of these integrated systems. These services are provided in commercial, education, healthcare, high tech, industrial, and special-hazard settings. Specialty Services segment includes providing a variety of infrastructure services and specialized industrial plant services, which include maintenance and repair of critical infrastructure such as underground electric, gas, water, sewer, and telecommunications infrastructure.